Shiseido has set a ¥13bn corporate bond offering under the shelf registration it made effective in April, the first disclosed use of a programme that can cover up to ¥300bn until April 24, 2028.
That is the clean headline number. The filing is less clean on what remains after this step. Its past-offerings table says there have been no earlier issuances or reductions under the shelf, while the remaining-amount section still shows ¥300bn. In other words, the document gives investors the size of this offering and the size of the overall programme, but it does not separately spell out a post-offering residual figure in the supplied extract.
| Feature | Disclosed value |
|---|---|
| Security type | Corporate bonds |
| This offering | ¥13bn |
| Past offerings under shelf | None listed |
| Planned shelf amount | ¥300bn |
| Remaining amount shown in filing | ¥300bn |
| Shelf effective period | April 25, 2026 to April 24, 2028 |
The disclosure also identifies the security type simply as corporate bonds. That makes this a debt-capacity update rather than an equity issuance disclosure. What the extract does not say is how the proceeds will be used. It also does not provide pricing details such as coupon, maturity or tranche split, so this supplement is more about confirming funding capacity than laying out the whole financing playbook.
For investors and lenders, that still has value. Shiseido now has an active shelf that runs to April 2028 and a disclosed first slice of ¥13bn against a much larger ¥300bn ceiling. The practical takeaway is modest but useful: the company has disclosed the first use of the programme, yet the public extract stops short of giving a neatly updated headroom number after this offering.